All Stories

  1. MC4R methylation and antipsychotic-related metabolic changes in early psychosis: findings from two prospective cohorts

    Article • Schizophrenia Research, May 2026, Elsevier

    Professor Gavin P Reynolds

  2. The pharmacology underlying the unique antipsychotic efficacy of clozapine

    Article • Journal of Psychopharmacology, August 2025, SAGE Publications

    Professor Gavin P Reynolds

  3. Air pollution and psychiatric outcomes - is Mendelian randomisation an appropriate analysis?

    Article • Journal of Affective Disorders, August 2025, Elsevier

    Professor Gavin P Reynolds

  4. Xanomeline/Trospium Combination

    Article • Journal of Clinical Psychopharmacology, June 2025, Wolters Kluwer Health

    Professor Gavin P Reynolds

  5. Proteomic associations with cognitive variability as measured by the Wisconsin Card Sorting Test in a healthy Thai population: A machine learning approach

    Article • PLOS One, February 2025, PLOS

    Professor Gavin P Reynolds

  6. Understanding the Therapeutic Action of Antipsychotics: Not yet Beyond Striatal Dopamine? A Comment on Direktor et al. (2024)

    Article • The International Journal of Neuropsychopharmacology, July 2024, Oxford University Press (OUP)

    Professor Gavin P Reynolds

  7. The trace amine-associated receptor 1 agonists – non-dopaminergic antipsychotics or covert modulators of D2 receptors?

    Article • Journal of Psychopharmacology, April 2024, SAGE Publications

    Professor Gavin P Reynolds

  8. Comment on Tabatabaei Dakhili et al. The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA:3-Ketoacid CoA Transferase. Diabetes 2023;72:126–134

    Article • Diabetes, April 2023, American Diabetes Association

    Professor Gavin P Reynolds

  9. Dopamine partial agonists: a discrete class of antipsychotics

    Article • International Journal of Psychiatry in Clinical Practice, December 2022, Taylor & Francis

    Professor Gavin P Reynolds

  10. Subchronic PCP effects on DNA methylation and protein expression of NMDA receptor subunit genes in the prefrontal cortex and hippocampus of female rats

    Article • Journal of Psychopharmacology, February 2022, SAGE Publications

    Professor Gavin P Reynolds

  11. The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin

    Article • Acta Neurovegetativa, December 2021, Springer Science + Business Media

    Professor Gavin P Reynolds

  12. High dose antipsychotic polypharmacy and dopamine partial agonists - time to rethink guidelines?

    Article • Journal of Psychopharmacology, July 2021, SAGE Publications

    Professor Gavin P Reynolds

  13. The Etiology of Metabolic Disturbances in Schizophrenia: Drugs, Genes, and Environment

    Article • The International Journal of Neuropsychopharmacology, July 2021, Oxford University Press (OUP)

    Professor Gavin P Reynolds

  14. Changes of BDNF exon IV DNA methylation are associated with methamphetamine dependence

    Article • Epigenomics, May 2021, Taylor & Francis

    Professor Gavin P Reynolds

  15. Early life trauma, DNA methylation and mental illness

    Article • Epigenomics, May 2021, Taylor & Francis

    Professor Gavin P Reynolds

  16. The relationship of childhood trauma and DNA methylation of NMDA receptor genes in first-episode schizophrenia

    Article • Epigenomics, May 2021, Taylor & Francis

    Professor Gavin P Reynolds

  17. Schizophrenia, Depressive Symptoms, and Antipsychotic Drug Treatment

    Article • The International Journal of Neuropsychopharmacology, January 2021, Oxford University Press (OUP)

    Professor Gavin P Reynolds

  18. Epigenetic-Mediated N -Methyl-D-Aspartate Receptor Changes in the Brain of Isolated Reared Rats

    Article • Epigenomics, November 2020, Taylor & Francis

    Professor Gavin P Reynolds

  19. Circulating microRNA changes in patients with impaired glucose regulation

    Article • Adipocyte, January 2020, Taylor & Francis

    Professor Gavin P Reynolds

  20. Agricultural work and reduced circulating uric acid are both associated with initial hospital admission for Parkinson’s disease

    Article • Acta Neurovegetativa, December 2019, Springer Science + Business Media

    Professor Gavin P Reynolds

  21. Neuromyelitis optica spectrum disorder in three generations of a Chinese family

    Article • Multiple Sclerosis and Related Disorders, July 2019, Elsevier

    Professor Gavin P Reynolds

  22. Adjunctive Lurasidone Suppresses Food Intake and Weight Gain Associated with Olanzapine Administration in Rats

    Article • Clinical Psychopharmacology and Neuroscience, May 2019, Korean College of Neuropsychopharmacology (KAMJE)

    Professor Gavin P Reynolds

  23. GRIN2B promoter methylation deficits in early-onset schizophrenia and its association with cognitive function

    Article • Epigenomics, February 2019, Future Medicine

    Professor Gavin P Reynolds

  24. Lower uric acid is associated with poor short-term outcome and a higher frequency of posterior arterial involvement in ischemic stroke

    Article • Neurological Sciences, March 2018, Springer Science + Business Media

    Professor Gavin P Reynolds

  25. Increased DNA methylation in the parvalbumin gene promoter is associated with methamphetamine dependence

    Article • Pharmacogenomics, August 2017, Future Medicine

    Professor Gavin P Reynolds, Sutisa Nudmamud-Thanoi

  26. Association of polymorphisms in GAD1 and GAD2 genes with methamphetamine dependence

    Article • Pharmacogenomics, January 2017, Future Medicine

    Professor Gavin P Reynolds, Sutisa Nudmamud-Thanoi

  27. DAT1 methylation is associated with methylphenidate response on oppositional and hyperactive-impulsive symptoms in children and adolescents with ADHD

    Article • The World Journal of Biological Psychiatry, September 2016, Taylor & Francis

    Professor Gavin P Reynolds

  28. Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine

    Article • Journal of Psychopharmacology, September 2016, SAGE Publications

    Professor Gavin P Reynolds

  29. Subchronic administration of phencyclidine produces hypermethylation in the parvalbumin gene promoter in rat brain

    Article • Epigenomics, September 2016, Future Medicine

    Professor Gavin P Reynolds

  30. Blood oxygen level-dependent signals via fMRI in the mood-regulating circuit using two animal models of depression are reversed by chronic escitalopram treatment

    Article • Behavioural Brain Research, September 2016, Elsevier

    Professor Gavin P Reynolds

  31. TPH-2 Polymorphisms Interact with Early Life Stress to Influence Response to Treatment with Antidepressant Drugs

    Article • The International Journal of Neuropsychopharmacology, August 2016, Oxford University Press (OUP)

    Professor Gavin P Reynolds

  32. Effect of Methamphetamine Exposure on Expression of Calcium Binding Proteins in Rat Frontal Cortex and Hippocampus

    Article • Neurotoxicity Research, May 2016, Springer Science + Business Media

    Professor Gavin P Reynolds

  33. BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment

    Article • Journal of Psychopharmacology, May 2016, SAGE Publications

    Professor Gavin P Reynolds

  34. Does DNA methylation influence the effects of psychiatric drugs?

    Article • Epigenomics, March 2016, Future Medicine

    Professor Gavin P Reynolds

  35. Does elevated peripheral benzodiazepine receptor gene expression relate to cognitive deficits in methamphetamine dependence?

    Article • Human Psychopharmacology Clinical and Experimental, February 2016, Wiley

    Professor Gavin P Reynolds, Sutisa Nudmamud-Thanoi

  36. Concurrent Risperidone Administration Attenuates the Development of Locomotor Sensitization Following Sub-Chronic Phencyclidine in Rats

    Article • Pharmacopsychiatry, February 2016, Thieme Publishing Group

    Professor Gavin P Reynolds

  37. Association of brain-derived neurotrophic factor valine to methionine polymorphism with sexual dysfunction following selective serotonin reuptake inhibitor treatment in female patients with major depressive disorder

    Article • Asia-Pacific Psychiatry, September 2015, Wiley

    Professor Gavin P Reynolds, ANNE YEE

  38. BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence

    Article • Pharmacogenomics, September 2015, Future Medicine

    Professor Gavin P Reynolds

  39. Genetic association of LMAN2L gene in schizophrenia and bipolar disorder and its interaction with ANK3 gene polymorphism

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, October 2014, Elsevier

    Professor Gavin P Reynolds

  40. Polymorphisms of serotonin neurotransmission and their effects on antipsychotic drug action

    Article • Pharmacogenomics, September 2014, Future Medicine

    Professor Gavin P Reynolds

  41. Analysis of sociability and preference for social novelty in the acute and subchronic phencyclidine rat

    Article • Journal of Psychopharmacology, August 2014, SAGE Publications

    Professor Gavin P Reynolds

  42. Numerical Methods on Population Balances

    Article • June 2014, Wiley

    Professor Gavin P Reynolds

  43. Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms

    Article • British Journal of Clinical Pharmacology, March 2014, Wiley

    Professor Gavin P Reynolds

  44. Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics

    Article • Pharmacogenomics, March 2014, Future Medicine

    Professor Gavin P Reynolds

  45. Methylation at a transcription factor-binding site on the 5-HT1A receptor gene correlates with negative symptom treatment response in first episode schizophrenia

    Article • The International Journal of Neuropsychopharmacology, December 2013, Oxford University Press (OUP)

    Professor Gavin P Reynolds

  46. Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone

    Article • Human Psychopharmacology Clinical and Experimental, November 2013, Wiley

    Professor Gavin P Reynolds

  47. SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects

    Article • Therapeutic Advances in Psychopharmacology, November 2013, SAGE Publications

    Professor Gavin P Reynolds

  48. Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia

    Article • The International Journal of Neuropsychopharmacology, November 2013, Oxford University Press (OUP)

    Professor Gavin P Reynolds

  49. Genetic variation of GRIN1 confers vulnerability to methamphetamine-dependent psychosis in a Thai population

    Article • Neuroscience Letters, September 2013, Elsevier

    Professor Gavin P Reynolds

  50. Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial

    Article • The Lancet Neurology, April 2013, Elsevier

    Professor Gavin P Reynolds

  51. Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population

    Article • Pharmacogenomics, April 2013, Future Medicine

    Professor Gavin P Reynolds

  52. Influence of genetic polymorphisms in the glutamatergic and GABAergic systems and their interactions with environmental stressors on antidepressant response

    Article • Pharmacogenomics, February 2013, Future Medicine

    Professor Gavin P Reynolds

  53. The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients

    Article • The International Journal of Neuropsychopharmacology, December 2012, Oxford University Press (OUP)

    Professor Gavin P Reynolds

  54. Histamine and antipsychotic drug-induced weight gain

    Article • Journal of Psychopharmacology, November 2012, SAGE Publications

    Professor Gavin P Reynolds

  55. Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration

    Article • BMC Medical Genetics, October 2012, Springer Science + Business Media

    Professor Gavin P Reynolds

  56. Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical Review

    Article • Clinical Psychopharmacology and Neuroscience, August 2012, Korean College of Neuropsychopharmacology (KAMJE)

    Professor Gavin P Reynolds

  57. An association between genotypic variations and protein expression of the glial glutamate transporter 2 in the human nucleus accumbens

    Article • Neuroscience Letters, August 2012, Elsevier

    Professor Gavin P Reynolds

  58. The Effect of Chronic Antipsychotic Drug on Hypothalamic Expression of Neural Nitric Oxide Synthase and Dopamine D2 Receptor in the Male Rat

    Article • PLOS One, April 2012, PLOS

    Professor Gavin P Reynolds

  59. Special issue on Pharmacogenetics

    Article • Journal of Psychopharmacology, February 2012, SAGE Publications

    Professor Gavin P Reynolds

  60. The Pharmacogenetics of Symptom Response to Antipsychotic Drugs

    Article • Psychiatry Investigation, January 2012, Korean Neuropsychiatric Association

    Professor Gavin P Reynolds

  61. The Pharmacogenetics of Antipsychotic Treatment

    Article • January 2012, Springer Science + Business Media

    Professor Gavin P Reynolds

  62. Learning and Memory Alterations Are Associated with Hippocampal N-acetylaspartate in a Rat Model of Depression as Measured by 1H-MRS

    Article • PLOS One, December 2011, PLOS

    Professor Gavin P Reynolds

  63. Receptor mechanisms of antipsychotic drug action in bipolar disorder – focus on asenapine

    Article • Therapeutic Advances in Psychopharmacology, December 2011, SAGE Publications

    Professor Gavin P Reynolds

  64. The Dose‐Dependent Effect of Chronic Administration of Haloperidol, Risperidone, and Quetiapine on Sexual Behavior in the Male Rat

    Article • The Journal of Sexual Medicine, December 2011, Elsevier

    Professor Gavin P Reynolds

  65. Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response

    Article • Journal of Psychopharmacology, September 2011, SAGE Publications

    Professor Gavin P Reynolds

  66. Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes

    Article • Pharmacogenomics, August 2011, Future Medicine

    Professor Gavin P Reynolds

  67. Functional consequences of twoHTR2Cpolymorphisms associated with antipsychotic-induced weight gain

    Article • Pharmacogenomics, May 2011, Future Medicine

    Professor Gavin P Reynolds

  68. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

    Article • Journal of Psychopharmacology, February 2011, SAGE Publications

    Professor Gavin P Reynolds

  69. Hippocampal neurochemistry is involved in the behavioural effects of neonatal maternal separation and their reversal by post-weaning environmental enrichment: A magnetic resonance study

    Article • Behavioural Brain Research, February 2011, Elsevier

    Professor Gavin P Reynolds

  70. Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder

    Article • Journal of Psychiatric Research, January 2011, Elsevier

    Professor Gavin P Reynolds

  71. Adolescent escitalopram administration modifies neurochemical alterations in the hippocampus of maternally separated rats

    Article • European Neuropsychopharmacology, December 2010, Elsevier

    Professor Gavin P Reynolds

  72. The physical health challenges in patients with severe mental illness: cardiovascular and metabolic risks

    Article • Journal of Psychopharmacology, July 2010, SAGE Publications

    Professor Gavin P Reynolds

  73. Clorgyline-mediated reversal of neurological deficits in a Complexin 2 knockout mouse

    Article • Human Molecular Genetics, June 2010, Oxford University Press (OUP)

    Professor Gavin P Reynolds

  74. Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism

    Article • Journal of Affective Disorders, June 2010, Elsevier

    Professor Gavin P Reynolds

  75. The effect of chronic antipsychotic drug administration on nitric oxide synthase activity and gene expression in rat penile tissues

    Article • European Neuropsychopharmacology, April 2010, Elsevier

    Professor Gavin P Reynolds

  76. Tryptophan depletion impairs object-recognition memory in the rat: Reversal by risperidone

    Article • Behavioural Brain Research, April 2010, Elsevier

    Professor Gavin P Reynolds

  77. Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat

    Article • Behavioural Brain Research, March 2010, Elsevier

    Professor Gavin P Reynolds

  78. Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat

    Article • Neuroscience Letters, March 2010, Elsevier

    Professor Gavin P Reynolds

  79. Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms

    Article • Pharmacology & Therapeutics, January 2010, Elsevier

    Professor Gavin P Reynolds

  80. Schizophrenia-related endophenotypes in heterozygous neuregulin-1 ‘knockout’ mice

    Article • European Journal of Neuroscience, January 2010, Wiley

    Professor Gavin P Reynolds

  81. Functional Pharmacogenetics of Serotonin Receptors in Psychiatric Drug Action

    Article • January 2010, Elsevier

    Professor Gavin P Reynolds

  82. Neonatal lipopolysaccharide induces pathological changes in parvalbumin immunoreactivity in the hippocampus of the rat

    Article • Behavioural Brain Research, December 2009, Elsevier

    Professor Gavin P Reynolds

  83. Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors

    Article • Psychopharmacology, August 2009, Springer Science + Business Media

    Professor Gavin P Reynolds

  84. Single drop behaviour in a high shear granulator

    Article • Powder Technology, January 2009, Elsevier

    Professor Gavin P Reynolds

  85. Disturbances in social interaction occur along with pathophysiological deficits following sub-chronic phencyclidine administration in the rat

    Article • Behavioural Brain Research, December 2008, Elsevier

    Professor Gavin P Reynolds

  86. The neurochemistry of schizophrenia

    Article • Psychiatry, October 2008, Elsevier

    Professor Gavin P Reynolds

  87. Effect of acute tryptophan depletion on noradrenaline and dopamine in the rat brain

    Article • Journal of Psychopharmacology, June 2008, SAGE Publications

    Professor Gavin P Reynolds

  88. PHARMACOGENETICS OF THE METABOLIC CONSEQUENCES OF ANTIPSYCHOTIC DRUGS

    Article • Schizophrenia Research, June 2008, Elsevier

    Professor Gavin P Reynolds

  89. PHARMACOGENETICS OF NEGATIVE SYMPTOM RESPONSE TO ANTIPSYCHOTIC DRUGS - THE ROLE OF 5-HT SYSTEMS

    Article • Schizophrenia Research, June 2008, Elsevier

    Professor Gavin P Reynolds

  90. Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia

    Article • The British Journal of Psychiatry, May 2008, Royal College of Psychiatrists

    Professor Gavin P Reynolds

  91. Erratum

    Article • Journal of Psychopharmacology, May 2008, SAGE Publications

    Professor Gavin P Reynolds

  92. Acute tryptophan depletion does not alter central or plasma brain-derived neurotrophic factor in the rat

    Article • European Neuropsychopharmacology, May 2008, Elsevier

    Professor Gavin P Reynolds

  93. Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats

    Article • Journal of Psychopharmacology, February 2008, SAGE Publications

    Professor Gavin P Reynolds

  94. The impact of pharmacogenetics on the development and use of antipsychotic drugs

    Article • Drug Discovery Today, November 2007, Elsevier

    Professor Gavin P Reynolds

  95. Sub-chronic phencyclidine administration increases brain-derived neurotrophic factor in the RAT hippocampus

    Article • Schizophrenia Research, August 2007, Elsevier

    Professor Gavin P Reynolds

  96. 5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity

    Article • Brain Research, May 2007, Elsevier

    Professor Gavin P Reynolds

  97. The neuronal pathology of schizophrenia: molecules and mechanisms: Table 1

    Article • Biochemical Society Transactions, April 2007, Portland Press Ltd.

    Professor Gavin P Reynolds

  98. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat

    Article • Journal of Psychopharmacology, March 2007, SAGE Publications

    Professor Gavin P Reynolds

  99. Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats

    Article • Acta Neurovegetativa, February 2007, Springer Science + Business Media

    Professor Gavin P Reynolds

  100. Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT2A receptor binding in the rat

    Article • Psychopharmacology, November 2006, Springer Science + Business Media

    Professor Gavin P Reynolds

  101. Subcellular Pathology of Human Neurodegenerative Disorders: Alzheimer-Type Dementia and Huntington's Disease

    Article • Journal of Neurochemistry, October 2006, Wiley

    Professor Gavin P Reynolds

  102. Effect of 5-HT1A Receptor Gene Polymorphism on Negative and Depressive Symptom Response to Antipsychotic Treatment of Drug-Naive Psychotic Patients

    Article • American Journal of Psychiatry, October 2006, American Psychiatric Association

    Professor Gavin P Reynolds

  103. The effect of chronic antipsychotic treatment on sexual behaviour, hormones and organ size in the male rat

    Article • Journal of Psychopharmacology, August 2006, SAGE Publications

    Professor Gavin P Reynolds

  104. Schizophrenia, antipsychotics and metabolic disease

    Article • Journal of Psychopharmacology, August 2006, SAGE Publications

    Professor Gavin P Reynolds

  105. Pharmacogenetics of schizophrenia

    Article • Expert Opinion on Pharmacotherapy, July 2006, Informa Healthcare

    Professor Gavin P Reynolds

  106. The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics

    Article • Journal of Psychopharmacology, July 2006, SAGE Publications

    Professor Gavin P Reynolds

  107. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm

    Article • Behavioural Brain Research, May 2006, Elsevier

    Professor Gavin P Reynolds

  108. Clozapine, but not haloperidol, increases neuropeptide Y neuronal expression in the rat hypothalamus

    Article • Journal of Psychopharmacology, January 2006, SAGE Publications

    Professor Gavin P Reynolds

  109. Selective increases in the cytokine, TNF , in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs

    Article • Journal of Psychopharmacology, January 2006, SAGE Publications

    Professor Gavin P Reynolds

  110. Metabolic syndrome and schizophrenia * Author's reply:

    Article • The British Journal of Psychiatry, January 2006, Royal College of Psychiatrists

    Professor Gavin P Reynolds

  111. Actions of antipsychotic drugs on pancreatic  -cell function: contrasting effects of clozapine and haloperidol

    Article • Journal of Psychopharmacology, November 2005, SAGE Publications

    Professor Gavin P Reynolds

  112. An in vitro model of inflammatory neurodegeneration and its neuroprotection

    Article • Neuroscience Letters, November 2005, Elsevier

    Professor Gavin P Reynolds

  113. The neurochemistry of schizophrenia

    Article • Psychiatry, October 2005, Elsevier

    Professor Gavin P Reynolds

  114. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, July 2005, Elsevier

    Professor Gavin P Reynolds

  115. Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol

    Article • Schizophrenia Research, June 2005, Elsevier

    Professor Gavin P Reynolds

  116. Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

    Article • Pharmacogenetics and Genomics, April 2005, Wolters Kluwer Health

    Professor Gavin P Reynolds

  117. Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain

    Article • Schizophrenia Research, March 2005, Elsevier

    Professor Gavin P Reynolds

  118. Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response

    Article • European Neuropsychopharmacology, March 2005, Elsevier

    Professor Gavin P Reynolds

  119. Chronic haloperidol or clozapine treatment does not alter parvalbumin immunoreactivity in the rat frontal cortex or hippocampus

    Article • Neuroscience Letters, December 2004, Elsevier

    Professor Gavin P Reynolds

  120. The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders

    Article • Neuroscience Letters, November 2004, Elsevier

    Professor Gavin P Reynolds

  121. Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat

    Article • European Journal of Pharmacology, November 2004, Elsevier

    Professor Gavin P Reynolds

  122. Receptor Mechanisms in the treatment of Schizophrenia

    Article • Journal of Psychopharmacology, September 2004, SAGE Publications

    Professor Gavin P Reynolds

  123. Reduced n-acetylaspartate in the temporal cortex of rats reared in isolation

    Article • Biological Psychiatry, August 2004, Elsevier

    Professor Gavin P Reynolds

  124. Calcium binding protein markers of GABA deficits in schizophrenia — post mortem studies and animal models

    Article • Neurotoxicity Research, January 2004, Springer Science + Business Media

    Professor Gavin P Reynolds

  125. Region specific changes in forebrain 5-hydroxytryptamine1a and 5-hydroxytryptamine2a receptors in isolation-reared rats: an in vitro autoradiography study

    Article • Neuroscience, January 2004, Elsevier

    Professor Gavin P Reynolds

  126. Effects of antipsychotics on fat deposition and changes in leptin and insulin levels: Magnetic resonance imaging study of previously untreated people with schizophrenia

    Article • The British Journal of Psychiatry, December 2003, Royal College of Psychiatrists

    Professor Gavin P Reynolds

  127. Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia

    Article • Psychiatric Genetics, September 2003, Wolters Kluwer Health

    Professor Gavin P Reynolds

  128. Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats

    Article • Neuroscience, June 2003, Elsevier

    Professor Gavin P Reynolds

  129. N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study

    Article • Biological Psychiatry, June 2003, Elsevier

    Professor Gavin P Reynolds

  130. Polymorphism of the Promoter Region of the Serotonin 5-HT 2C Receptor Gene and Clozapine-Induced Weight Gain

    Article • American Journal of Psychiatry, April 2003, American Psychiatric Association

    Professor Gavin P Reynolds

  131. The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat

    Article • Journal of Psychopharmacology, January 2003, SAGE Publications

    Professor Gavin P Reynolds

  132. Increased Concentrations of the Neurotoxin 3-Hydroxykynurenine in the Frontal Cortex of HIV-1-Positive Patients

    Article • Journal of Neurochemistry, November 2002, Wiley

    Professor Gavin P Reynolds

  133. Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?

    Article • Journal of Neurochemistry, November 2002, Wiley

    Professor Gavin P Reynolds

  134. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins

    Article • Biological Psychiatry, October 2002, Elsevier

    Professor Gavin P Reynolds

  135. Weight gain, antipsychotic drug treatment and pharmacogenomics

    Article • Pharmacogenomics, September 2002, Taylor & Francis

    Professor Gavin P Reynolds

  136. Neuronal calcium-binding proteins and schizophrenia

    Article • Schizophrenia Research, September 2002, Elsevier

    Professor Gavin P Reynolds

  137. The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism

    Article • Journal of Psychiatric Research, September 2002, Elsevier

    Professor Gavin P Reynolds

  138. Association of a polymorphism in the promoter region of the serotonin 5-HT2C receptor gene with tardive dyskinesia in patients with schizophrenia

    Article • Molecular Psychiatry, August 2002, Nature

    Professor Gavin P Reynolds

  139. Association of antipsychotic druginduced weight gain with a 5-HT2C receptor gene polymorphism

    Article • The Lancet, June 2002, Elsevier

    Professor Gavin P Reynolds

  140. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia

    Article • Schizophrenia Research, May 2002, Elsevier

    Professor Gavin P Reynolds

  141. Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons

    Article • Acta Neurovegetativa, May 2002, Springer Science + Business Media

    Professor Gavin P Reynolds

  142. The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease

    Article • Journal of Neurochemistry, March 2002, Wiley

    Professor Gavin P Reynolds

  143. The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study

    Article • Journal of Psychopharmacology, January 2002, SAGE Publications

    Professor Gavin P Reynolds

  144. Brain Neurotransmitter Deficits in Mice Transgenic for the Huntington’s Disease Mutation

    Article • Journal of Neurochemistry, December 2001, Wiley

    Professor Gavin P Reynolds

  145. Phospholipid fatty acids and neurotoxicity in human neuroblastoma SH-SY5Y cells

    Article • Neuroscience Letters, August 2001, Elsevier

    Professor Gavin P Reynolds

  146. GABAergic neuronal subtypes in the human frontal cortex — development and deficits in schizophrenia

    Article • Journal of Chemical Neuroanatomy, July 2001, Elsevier

    Professor Gavin P Reynolds

  147. Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity

    Article • Brain Research Bulletin, July 2001, Elsevier

    Professor Gavin P Reynolds

  148. Increased density of glutamate/N-methyl-d-aspartate receptors in superior temporal cortex in schizophrenia

    Article • Neuroscience Letters, May 2001, Elsevier

    Professor Gavin P Reynolds

  149. Antipsychotic drug use in neurodegenerative disease in the elderly: problems and potential from a pharmacological perspective

    Article • Expert Opinion on Pharmacotherapy, April 2001, Informa Healthcare

    Professor Gavin P Reynolds

  150. Plasma homovanillic acid in untreated schizophrenia — relationship with symptomatology and sex

    Article • Journal of Psychiatric Research, January 2001, Elsevier

    Professor Gavin P Reynolds

  151. Agonist-stimulated GTPγ[35S] binding to 5-HT1A receptors in human post-mortem brain

    Article • European Journal of Pharmacology, December 1999, Elsevier

    Professor Gavin P Reynolds

  152. Dopamine receptors, antipsychotic action and schizophrenia

    Article • Journal of Psychopharmacology, March 1999, SAGE Publications

    Professor Gavin P Reynolds

  153. Antipsychotic drug affinities at α2-adrenoceptor subtypes in post-mortem human brain

    Article • Journal of Psychopharmacology, March 1998, SAGE Publications

    Professor Gavin P Reynolds

  154. Developments in antipsychotic drugs – an update

    Article • Expert Opinion on Investigational Drugs, February 1998, Informa Healthcare

    Professor Gavin P Reynolds

  155. Receptor mechanisms of antipsychotic drug atypicality

    Article • European Psychiatry, January 1998, Cambridge University Press

    Professor Gavin P Reynolds

  156. Receptor mechanisms of antipsychotic drug atypicality

    Article • European Psychiatry, January 1998, Cambridge University Press

    Professor Gavin P Reynolds

  157. Increased density of glutamate/N-methyl-d-aspartate receptors in putamen from schizophrenic patients

    Article • Neuroscience Letters, January 1998, Elsevier

    Professor Gavin P Reynolds

  158. Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease

    Article • Neuroscience Letters, January 1998, Elsevier

    Professor Gavin P Reynolds

  159. S.17.03 Antipsychotic drugs and neurotransmitter receptor regulation

    Article • European Neuropsychopharmacology, September 1997, Elsevier

    Professor Gavin P Reynolds

  160. Deficits of [3H]d-aspartate binding to glutamate uptake sites in striatal and accumbens tissue in patients with schizophrenia

    Article • Neuroscience Letters, August 1997, Elsevier

    Professor Gavin P Reynolds

  161. What is an atypical antipsychotic?

    Article • Journal of Psychopharmacology, July 1997, SAGE Publications

    Professor Gavin P Reynolds

  162. Schizophrenia - advances in drug therapy

    Article • Expert Opinion on Investigational Drugs, July 1997, Informa Healthcare

    Professor Gavin P Reynolds

  163. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics

    Article • Schizophrenia Research, April 1997, Elsevier

    Professor Gavin P Reynolds

  164. 5-HT receptors, genes and antipsychotic mechanisms

    Article • Journal of Psychopharmacology, January 1997, SAGE Publications

    Professor Gavin P Reynolds

  165. An improved model for examining delayed excitotoxic neurodegeneration in isolated chick retina

    Article • Neuroscience Letters, November 1996, Elsevier

    Professor Gavin P Reynolds

  166. Neurotransmitter receptors, genes and schizophrenia

    Article • European Neuropsychopharmacology, September 1996, Elsevier

    Professor Gavin P Reynolds

  167. Imidazoline binding sites in Huntington's and Parkinson's disease putamen

    Article • European Journal of Pharmacology, April 1996, Elsevier

    Professor Gavin P Reynolds

  168. The Importance of Dopamine D4 Receptors in the Action and Development of Antipsychotic Agents

    Article • Drugs, January 1996, Springer Science + Business Media

    Professor Gavin P Reynolds

  169. Characterization of [3H]GR 113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders

    Article • Behavioural Brain Research, December 1995, Elsevier

    Professor Gavin P Reynolds

  170. Consensus on minimal criteria of clinical and neuropathological diagnosis of schizophrenia and affective disorders for post mortem research

    Article • Acta Neurovegetativa, October 1995, Springer Science + Business Media

    Professor Gavin P Reynolds

  171. Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia

    Article • European Journal of Pharmacology, August 1995, Elsevier

    Professor Gavin P Reynolds

  172. Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients

    Article • Journal of Psychiatric Research, May 1995, Elsevier

    Professor Gavin P Reynolds

  173. 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases

    Article • British Journal of Pharmacology, March 1995, Wiley

    Professor Gavin P Reynolds

  174. An investigation of the activities of 3-hydroxykynureninase and kynurenine aminotransferase in the brain in Huntington's disease

    Article • Acta Neurovegetativa, February 1995, Springer Science + Business Media

    Professor Gavin P Reynolds

  175. Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia

    Article • Neuroscience Letters, February 1995, Elsevier

    Professor Gavin P Reynolds

  176. New Approaches to the Drug Treatment of Schizophrenia

    Article • January 1995, Elsevier

    Professor Gavin P Reynolds

  177. Neurotransmitter Systems in Schizophrenia

    Article • January 1995, Elsevier

    Professor Gavin P Reynolds

  178. Neocortical neurotransmitter markers in Huntington's disease

    Article • Acta Neurovegetativa, October 1994, Springer Science + Business Media

    Professor Gavin P Reynolds

  179. Arachidonic Acid: A Common Link in the Biology of Schizophrenia?

    Article • Archives of General Psychiatry, August 1994, American Medical Association (AMA)

    Professor Gavin P Reynolds

  180. Deficit of [3H]L-689,560 binding to the glycine site of the glutamate/NMDA receptor in the brain in Huntington's disease

    Article • Journal of the Neurological Sciences, August 1994, Elsevier

    Professor Gavin P Reynolds

  181. Glutamate in Huntington's disease

    Article • The Lancet, July 1994, Elsevier

    Professor Gavin P Reynolds

  182. Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia

    Article • Acta Psychiatrica Scandinavica, May 1994, Wiley

    Professor Gavin P Reynolds

  183. Differential regulation of cardiac α- and β-adrenoceptors by the sympathetic nervous system

    Article • Journal of Autonomic Pharmacology, February 1994, Wiley

    Professor Gavin P Reynolds

  184. Glutamate stimulates dopamine release from cortical and limbic rat brain in vitro

    Article • European Journal of Pharmacology, September 1993, Elsevier

    Professor Gavin P Reynolds

  185. D-aspartate binding to the glutamate uptake site in human brain tissue ? effects of leucotomy

    Article • Acta Neurovegetativa, June 1993, Springer Science + Business Media

    Professor Gavin P Reynolds

  186. Hippocampal benzodiazepine receptors in schizophrenia

    Article • Acta Neurovegetativa, June 1993, Springer Science + Business Media

    Professor Gavin P Reynolds

  187. Hippocampal tin, aluminum and zinc in Alzheimer's disease

    Article • BioMetals, January 1993, Springer Science + Business Media

    Professor Gavin P Reynolds

  188. Monoamine neurotransmitters and their metabolites in brain regions in alzheimer's disease: A postmortem study

    Article • Cellular and Molecular Neurobiology, December 1992, Springer Science + Business Media

    Professor Gavin P Reynolds

  189. Neurochemical abnormalities in huntington's disease: Neurotoxic mechanisms and neurotransmitter changes

    Article • Journal of the Neurological Sciences, December 1992, Elsevier

    Professor Gavin P Reynolds

  190. Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissue

    Article • European Journal of Pharmacology, October 1992, Elsevier

    Professor Gavin P Reynolds

  191. Dopamine receptor abnormalities in the striatum and pallidum in tardive dyskinesia: a post mortem study

    Article • Acta Neurovegetativa, October 1992, Springer Science + Business Media

    Professor Gavin P Reynolds

  192. Pre-frontal structural and functional deficits associated with individual differences in schizotypal personality

    Article • Schizophrenia Research, September 1992, Elsevier

    Professor Gavin P Reynolds

  193. Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease

    Article • Neuroscience Letters, September 1992, Elsevier

    Professor Gavin P Reynolds

  194. An evaluation of structural and functional prefrontal deficits in schizophrenia: MRI and neuropsychological measures

    Article • Psychiatry Research Neuroimaging, August 1992, Elsevier

    Professor Gavin P Reynolds

  195. Developments in the drug treatment of schizophrenia

    Article • Trends in Pharmacological Sciences, January 1992, Elsevier

    Professor Gavin P Reynolds

  196. Erratum

    Article • Trends in Pharmacological Sciences, January 1992, Elsevier

    Professor Gavin P Reynolds

  197. Erratum

    Article • Trends in Pharmacological Sciences, January 1992, Elsevier

    Professor Gavin P Reynolds

  198. Studies on brain monoamine oxidase: a laboratory investigation in neurochemistry for first-year undergraduates

    Article • Biochemical Education, January 1992, Elsevier

    Professor Gavin P Reynolds

  199. The ratio of plasma phenylalanine to other large neutral amino acids is not a risk factor for tardive dyskinesia

    Article • Journal of Psychopharmacology, January 1992, SAGE Publications

    Professor Gavin P Reynolds

  200. Neuroanatomical Correlates of Skin Conductance Orienting in Normal Humans: A Magnetic Resonance Imaging Study

    Article • Psychophysiology, September 1991, Wiley

    Professor Gavin P Reynolds

  201. Electrochemical detection of human brain transmitter amino acids by high-performance liquid chromatography of stable O-phthalaldehyde-sulphite derivatives

    Article • Acta Neurovegetativa, June 1991, Springer Science + Business Media

    Professor Gavin P Reynolds

  202. Determination of 3-hydroxykynurenine in human brain and plasma by high-performance liquid chromatography with electrochemical detection

    Article • Journal of Chromatography B Biomedical Sciences and Applications, April 1991, Elsevier

    Professor Gavin P Reynolds

  203. [3H]Ditolylguanidine binding to human brain σ sites is diminished after haloperidol treatment

    Article • European Journal of Pharmacology, March 1991, Elsevier

    Professor Gavin P Reynolds

  204. No deficit of pallidal D2 dopamine receptors in Huntington's disease

    Article • Journal of the Neurological Sciences, December 1990, Elsevier

    Professor Gavin P Reynolds

  205. Structural and Functional Characteristics of the Corpus Callosum in Schizophrenics, Psychiatric Controls, and Normal Controls

    Article • Archives of General Psychiatry, November 1990, American Medical Association (AMA)

    Professor Gavin P Reynolds

  206. Pallidal GABA and chorea in Huntington's disease

    Article • Acta Neurovegetativa, October 1990, Springer Science + Business Media

    Professor Gavin P Reynolds

  207. [3H]Nipecotic Acid Binding to ?-Aminobutyric Acid Uptake Sites in Postmortem Human Brain

    Article • Journal of Neurochemistry, July 1990, Wiley

    Professor Gavin P Reynolds

  208. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia

    Article • Biological Psychiatry, May 1990, Elsevier

    Professor Gavin P Reynolds

  209. Dementia in Huntington's disease is associated with neurochemical deficits in the caudate nucleus, not the cerebral cortex

    Article • Neuroscience Letters, May 1990, Elsevier

    Professor Gavin P Reynolds

  210. Serotonin concentrations and turnover in brains of depressed suicides

    Article • Brain Research, November 1989, Elsevier

    Professor Gavin P Reynolds

  211. Tissue banking and EURAGE

    Article • Journal of the Neurological Sciences, November 1989, Elsevier

    Professor Gavin P Reynolds

  212. INCREASED BRAIN 3-HYDROXYKYNURENINE IN HUNTINGTON'S DISEASE

    Article • The Lancet, October 1989, Elsevier

    Professor Gavin P Reynolds

  213. (3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

    Article • Acta Neurovegetativa, June 1989, Springer Science + Business Media

    Professor Gavin P Reynolds

  214. [3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia

    Article • Acta Neurovegetativa, June 1989, Springer Science + Business Media

    Professor Gavin P Reynolds

  215. Frontal Cortical and Left Temporal Glutamatergic Dysfunction in Schizophrenia

    Article • Journal of Neurochemistry, June 1989, Wiley

    Professor Gavin P Reynolds

  216. Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata

    Article • Neuroscience Letters, May 1989, Elsevier

    Professor Gavin P Reynolds

  217. Neuropeptides in Alzheimer's disease: a postmortem study

    Article • Regulatory Peptides, April 1989, Elsevier

    Professor Gavin P Reynolds

  218. Reduced d-[3H]aspartate binding in Down's syndrome brains

    Article • Brain Research, April 1989, Elsevier

    Professor Gavin P Reynolds

  219. Alzheimer-like cortical amino-acid changes in elderly Down's syndrome

    Article • Journal of Neural Transmission - Parkinsons Disease and Dementia Section, March 1989, Springer Science + Business Media

    Professor Gavin P Reynolds

  220. 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms

    Article • Acta Neurovegetativa, February 1989, Springer Science + Business Media

    Professor Gavin P Reynolds

  221. Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

    Article • Journal of Neurochemistry, February 1989, Wiley

    Professor Gavin P Reynolds

  222. ALUMINIUM AND ALZHEIMER'S DISEASE

    Article • The Lancet, February 1989, Elsevier

    Professor Gavin P Reynolds

  223. Amino acid neurotransmitter deficits in adult Down's syndrome brain tissue

    Article • Neuroscience Letters, November 1988, Elsevier

    Professor Gavin P Reynolds

  224. Post-mortem neurochemistry of schizophrenia

    Article • Psychological Medicine, November 1988, Cambridge University Press

    Professor Gavin P Reynolds

  225. GLUTAMATE DEHYDROGENASE ACTIVITY IN AMYOTROPHIC LATERAL SCLEROSIS

    Article • The Lancet, October 1988, Elsevier

    Professor Gavin P Reynolds

  226. Pathologic Heterogeneity of Alzheimer's Disease-Reply

    Article • Archives of General Psychiatry, October 1988, American Medical Association (AMA)

    Professor Gavin P Reynolds

  227. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

    Article • Acta Neurovegetativa, October 1988, Springer Science + Business Media

    Professor Gavin P Reynolds

  228. Depletion of monoamine transmitters by tetrabenazine in brain tissue in Huntington's disease

    Article • Neuropharmacology, July 1988, Elsevier

    Professor Gavin P Reynolds

  229. Brain Quinolinic Acid in Huntington's Disease

    Article • Journal of Neurochemistry, June 1988, Wiley

    Professor Gavin P Reynolds

  230. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea

    Article • Neuroscience, May 1988, Elsevier

    Professor Gavin P Reynolds

  231. ASYMMETRICAL LOSS OF GLUTAMATE RECEPTOR SUBTYPE IN LEFT HIPPOCAMPUS IN SCHIZOPHRENIA

    Article • The Lancet, March 1988, Elsevier

    Professor Gavin P Reynolds

  232. Human cytomegalovirus DNA in the temporal cortex of a schizophrenic patient

    Article • European Archives of Psychiatry and Neurological Sciences, March 1988, Springer Science + Business Media

    Professor Gavin P Reynolds

  233. A correlative study on hippocampal cation shifts and amino acids and clinico-pathological data in Alzheimer's disease

    Article • Neurobiology of Aging, November 1987, Elsevier

    Professor Gavin P Reynolds

  234. Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain

    Article • Neuroscience Letters, July 1987, Elsevier

    Professor Gavin P Reynolds

  235. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.

    Article • Journal of Neurology Neurosurgery & Psychiatry, June 1987, BMJ

    Professor Gavin P Reynolds

  236. Age and Histopathologic Heterogeneity in Alzheimer's Disease

    Article • Archives of General Psychiatry, May 1987, American Medical Association (AMA)

    Professor Gavin P Reynolds

  237. DOPAMINE RECEPTOR ASYMMETRY IN SCHIZOPHRENIA

    Article • The Lancet, April 1987, Elsevier

    Professor Gavin P Reynolds

  238. HPLC analysis of somatostatin related peptides in putamen of Huntington's Disease patients

    Article • Acta Neurovegetativa, March 1987, Springer Science + Business Media

    Professor Gavin P Reynolds

  239. Maintenance of cortical somatostatin and monoamine levels in the rat does not require intact cholinergic innervation

    Article • Brain Research, March 1987, Elsevier

    Professor Gavin P Reynolds

  240. Decreased brown adipose tissue thermogenic activity following a reduction in brain serotonin by intraventricular p-chlorophenylalanine

    Article • Bioscience Reports, February 1987, Portland Press Ltd.

    Professor Gavin P Reynolds

  241. A disorder of cortical GABAergic innervation in Alzheimer's disease

    Article • Neuroscience Letters, January 1987, Elsevier

    Professor Gavin P Reynolds

  242. Human brain dopamine receptors in children and aging adults

    Article • Synapse, January 1987, Wiley

    Professor Gavin P Reynolds

  243. Neuropathology of Huntington's disease

    Article • Trends in Neurosciences, January 1987, Elsevier

    Professor Gavin P Reynolds

  244. Region-specific loss of glutamate innervation in Alzheimer's disease

    Article • Neuroscience Letters, January 1987, Elsevier

    Professor Gavin P Reynolds

  245. LITHIUM PROPHYLAXIS INHIBITS CHOLINE TRANSPORT IN POST-MORTEM BRAIN

    Article • The Lancet, August 1986, Elsevier

    Professor Gavin P Reynolds

  246. Monoclonal antibodies raised against a subsequence of senile plaque core protein react with plaque cores, plaque periphery and cerebrovascular amyloid in Alzheimer's disease

    Article • Neuroscience Letters, July 1986, Elsevier

    Professor Gavin P Reynolds

  247. Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease

    Article • Neuroscience Letters, June 1986, Elsevier

    Professor Gavin P Reynolds

  248. Regional distribution of a novel peptide (P7 of 1B236) immunoreactivity in the human central nervous system

    Article • Neuroscience Letters, June 1986, Elsevier

    Professor Gavin P Reynolds

  249. Striatal dopamine and homovanillic acid in Huntington's Disease

    Article • Acta Neurovegetativa, June 1986, Springer Science + Business Media

    Professor Gavin P Reynolds

  250. Cytological brush entrapment: a hazard in the stomach postoperatively.

    Article • BMJ, May 1986, BMJ

    Professor Gavin P Reynolds

  251. Dopamine D2 receptor density remains constant in treated Parkinson's disease

    Article • Annals of Neurology, May 1986, Wiley

    Professor Gavin P Reynolds

  252. Brain serotonin receptors in Huntington's disease

    Article • Neurochemistry International, January 1986, Elsevier

    Professor Gavin P Reynolds

  253. Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations

    Article • JAMA, December 1985, American Medical Association (AMA)

    Professor Gavin P Reynolds

  254. Corticotropin-Releasing Factor-like Immunoreactivity in Senile Dementia of the Alzheimer Type

    Article • JAMA, December 1985, American Medical Association (AMA)

    Professor Gavin P Reynolds

  255. ALZHEIMER-LIKE BRAIN MONOAMINE DEFICITS IN ADULTS WITH DOWN'S SYNDROME

    Article • The Lancet, December 1985, Elsevier

    Professor Gavin P Reynolds

  256. Recombinant DNA studies on stored necropsy brain samples from patients with Huntington's chorea.

    Article • Journal of Clinical Pathology, October 1985, BMJ

    Professor Gavin P Reynolds

  257. [3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease

    Article • European Journal of Pharmacology, August 1985, Elsevier

    Professor Gavin P Reynolds

  258. Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the adrenal glands as well as the brain in the marmoset

    Article • Neuroscience Letters, July 1985, Elsevier

    Professor Gavin P Reynolds

  259. Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and γ-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases

    Article • Journal of the Neurological Sciences, February 1985, Elsevier

    Professor Gavin P Reynolds

  260. Identification of gram-negative bacilli using the autobac IDX

    Article • Diagnostic Microbiology and Infectious Disease, January 1985, Elsevier

    Professor Gavin P Reynolds

  261. Decreased Proline Endopeptidase Activity in the Basal Ganglia in Huntington's Disease

    Article • Journal of Neurochemistry, September 1984, Wiley

    Professor Gavin P Reynolds

  262. TETRAHYDROBIOPTERIN METABOLISM IN DEPRESSION

    Article • The Lancet, July 1984, Elsevier

    Professor Gavin P Reynolds

  263. Noradrenaline and schizophrenia

    Article • Trends in Pharmacological Sciences, January 1984, Elsevier

    Professor Gavin P Reynolds

  264. Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type

    Article • Neuroscience Letters, January 1984, Elsevier

    Professor Gavin P Reynolds

  265. The pharmacology of Parkinson's disease: l-dopa and beyond

    Article • Trends in Pharmacological Sciences, January 1984, Elsevier

    Professor Gavin P Reynolds

  266. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

    Article • Nature, October 1983, Nature

    Professor Gavin P Reynolds

  267. Neuropharmacology: Pathophysiology of schizophrenia — causal role for dopamine or noradrenaline?

    Article • Nature, October 1983, Nature

    Professor Gavin P Reynolds

  268. SEROTONIN RECEPTORS IN SUICIDE VICTIMS

    Article • The Lancet, October 1983, Elsevier

    Professor Gavin P Reynolds

  269. Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of alzheimer's type

    Article • Neuroscience Letters, August 1983, Elsevier

    Professor Gavin P Reynolds

  270. Chronic clozapine treatment of rats down-regulates cortical 5-HT2 receptors

    Article • European Journal of Pharmacology, May 1983, Elsevier

    Professor Gavin P Reynolds

  271. Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients

    Article • Psychiatry Research, April 1983, Elsevier

    Professor Gavin P Reynolds

  272. Neurotensin in the adrenal medulla

    Article • Neuroscience Letters, February 1983, Elsevier

    Professor Gavin P Reynolds

  273. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls

    Article • Archiv für Psychiatrie und Nervenkrankheiten, December 1982, Springer Science + Business Media

    Professor Gavin P Reynolds

  274. Parkinson's disease putamen: Normal concentration of synaptic membrane marker antigens

    Article • Acta Neurovegetativa, September 1982, Springer Science + Business Media

    Professor Gavin P Reynolds

  275. THIORIDAZINE IS NOT SPECIFIC FOR LIMBIC DOPAMINE RECEPTORS

    Article • The Lancet, August 1982, Elsevier

    Professor Gavin P Reynolds

  276. Determination of a wide range of urinary amine metabolites using a simple high-performance liquid chromatographic technique

    Article • Journal of Chromatography B Biomedical Sciences and Applications, September 1981, Elsevier

    Professor Gavin P Reynolds

  277. DOPAMINE RECEPTORS IN POST-MORTEM SCHIZOPHRENIC BRAINS

    Article • The Lancet, June 1981, Elsevier

    Professor Gavin P Reynolds

  278. The effects of lisuride and some other dopaminergic agonists on receptor binding in human brain

    Article • Acta Neurovegetativa, March 1981, Springer Science + Business Media

    Professor Gavin P Reynolds

  279. DOPAMINE RECEPTORS AND SCHIZOPHRENIA: DRUG EFFECT OR ILLNESS

    Article • The Lancet, December 1980, Elsevier

    Professor Gavin P Reynolds

  280. The Determination and Distribution of2-Phenylethylamine in Sheep Brain

    Article • Journal of Neurochemistry, May 1980, Wiley

    Professor Gavin P Reynolds

  281. Deficient production of tyramine and octopamine in cases of depression

    Article • Nature, March 1979, Nature

    Professor Gavin P Reynolds

  282. Phenylethylamine — a role in mental illness?

    Article • Trends in Neurosciences, January 1979, Elsevier

    Professor Gavin P Reynolds

  283. Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration

    Article • Acta Neurovegetativa, September 1978, Springer Science + Business Media

    Professor Gavin P Reynolds

  284. The effect of urinary pH and flow rate on monoamine output

    Article • Clinica Chimica Acta, March 1978, Elsevier

    Professor Gavin P Reynolds

  285. The urinary excretion of 2-phenylethylamine in phenylketonuria

    Article • Clinica Chimica Acta, February 1978, Elsevier

    Professor Gavin P Reynolds

  286. Deprenyl administration in man: A selective monoamine oxidase B inhibitor without the ?cheese effect?

    Article • Psychopharmacology, January 1978, Springer Science + Business Media

    Professor Gavin P Reynolds

  287. Gas chromatographic detection of N-methyl-2-phenylethylamine: a new component of human urine

    Article • Journal of Chromatography B Biomedical Sciences and Applications, January 1978, Elsevier

    Professor Gavin P Reynolds

  288. A method for the estimation of 2-phenylethylamine in human urine by gas chromatography

    Article • Clinica Chimica Acta, July 1976, Elsevier

    Professor Gavin P Reynolds

  289. Neurochemical Studies in Human Postmortem Brain Tissue

    Article • Springer Science + Business Media

    Professor Gavin P Reynolds

  290. Neurochemistry of Human Postmortem Brain

    Article • Springer Science + Business Media

    Professor Gavin P Reynolds